| 发明名称 |
PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS |
| 摘要 |
An effective Pseudomonas aeruginosa vaccine may require one or several antigenic components, and so various antigens of P. aeruginosa are identified for use in immunisation. These polypeptides may optionally be used in combination with other nosocomial antigens. |
| 申请公布号 |
US2015322116(A1) |
申请公布日期 |
2015.11.12 |
| 申请号 |
US201314648198 |
申请日期 |
2013.11.27 |
| 申请人 |
NOVARTIS AG ;OSPEDALE SAN RAFFAELE SRL |
发明人 |
MASIGNANI Vega;SCARSELLI Maria;PETRACCA Roberto;BIANCONI Irene;BRAGONZI Alessandra;ALCALA' FRANCO Beatriz |
| 分类号 |
C07K14/21;A61K47/48;A61K39/385;A61K39/104;A61K39/39 |
主分类号 |
C07K14/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An immunogenic composition comprising one or more antigens selected from the list of: a PSE54 (PA5340) antigen; a PSE44-4 (PA3526) antigen; a PSE10-1 (PA1178) antigen; a PSE21-5 (PA5112) antigen; a PSE27-1 (PA0328) antigen; a PSE52-1 (PA4765) antigen; a PSE53-1 (PA5047) antigen; PSE11-3 (PA1248) antigen; a PSE41-5 (PA2407) antigen; a PSE47A-2 (PA4082); PSE5-1 (PA0595); PSE13-2 (PA1954); PSE17-1 (PA3692); PSE18-2 (PA4370); PSE20-1 (PA4735); PSE23-1 (PA3647); PSE24-1 (PA0126); PSE25-1 (PA0189); PSE26-1 (PA0274); PSE28-2 (PA0537); PSE31-2 (PA0737); PSE33-2 (PA1086); PSE42-1 (PA2793); PSE45-2 (PA3535); PSE50-1 (PA4578); PSE51-4 (PA4667); PSE19-1 (PA4710); PSE34-1 (PA1106); PSE36-3 (PA1324); PSE38-1 (PA1777). |
| 地址 |
Basel CH |
